Peripheral lymphoid cells, from 3 cases of acute infectious mononucleosis (IM) and 2 cases of healthy individuals, were tested in a colony inhibition assay for cytotoxic activity against two cell lines that did or did not carry the Epstein-Barr virus (EBV) genome, A2L/AH and Ad cells respectively. T-lymphocyte fraction of IM was specifically cytotoxic for EBV-genome carrying cells and the residual lymphocyte fraction had high ADCC but low NK activity compared to the normal donors. When the A2L/AH cells which were forced to enter the EBV-cycle by n-butyrate treatment used as target cells, B-cell enriched fraction showed increased cytotoxic effect that was more remarkable in NK activity than ADCC in normal donors. These results were considered to be useful for possible specific immuno-therapy in nasopharyngeal carcinoma.
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